Bph treatment

The UroLift® System permanent implants, delivered during a minimally-invasive procedure, act like window curtain tie-backs to hold the lobes of an enlarged prostate open. Patients recover from the procedure quickly, and return to their normal routines with minimal downtime.

Data from clinical trials showed that patients receiving UroLift® implants reported rapid symptomatic improvement, improved urinary flow rates, and sustained sexual function. Patients also experienced a significant improvement in quality of life. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure.

About BPH Treatment

More than 500 million aging men worldwide have an enlarged prostate. Medication is often the first line therapy but relief can be inadequate and temporary. Side effects of treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts or ablates prostate tissue to open the blocked urethra. While current surgical options, such as the ‘gold standard’ surgery, Transurethral Resection of the Prostate (TURP), can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction and retrograde ejaculation (dry orgasm).

About UroLift®

The UroLift® System provides an alternative to tissue removing surgery for the treatment of an enlarged prostate. Performed through the urethra, a urologist uses the UroLift® System to push aside the obstructive prostate lobes and positions small, tailored permanent UroLift® implants to hold the prostate lobes in the retracted position. This opens the urethra while leaving the prostate intact. Adverse reactions associated with UroLift® System treatment were comparable to other minimally invasive surgical therapies as well as standard cystoscopy. The most common adverse events reported during the study included pain or burning with urination, blood in the urine, pelvic pain, urgent need to urinate, and the inability to control urine because of an urgent need to urinate. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure.


Contact University Urology for more information on the UroLift® System.


University Urology
215 Lexington Avenue 20th Floor
New York, New York 10016
(212) 686-9015

Book an Appointment Now

Dr. Jed Kaminetsky, M.D. is a Clinical Assistant Professor at NYU Medical Center and a Board Certified Urologist.

Our mission here at University Urology Associates is to render the absolute best in urologic specialty care to our patients through decades of experience, cutting edge technology, and medical research

What Are the Long Term Risks of BPH?

If left untreated, it can progress and cause subsequent medical issues. If your bladder does not empty completely, you become at risk for developing urinary tract infections (UTIs). Over time bladder stones, blood in the urine (Hematuria), incontinence, or urinary retention can occur. In rare cases, bladder and/or kidney damage can develop.

Questions? Ask Here.

More on Men’s Health

Premature Ejaculation
Erectile Dysfunction
Low Testosterone
Voiding Difficulties

The UroLift® System is a revolutionary, minimally invasive procedure.